| ERG |
clone 9FY |
ERG, 99.9% specific for prostate carcinoma with clone 9FY. No cross- reactivity with infiltrating T- and B- cells. ERG expression offers a rare, but definitive marker for adenocarcinoma of prostatic origin, and a unique opportunity to identify a potentially clinically significant subset of prostate cancer patients by IHC, a single stain slide. |
